Home/Filings/3/0001213900-24-044072
3//SEC Filing

ALPHA PHARMA Investments LLC 3

Accession 0001213900-24-044072

CIK 0001563577other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 10:26 AM ET

Size

6.8 KB

Accession

0001213900-24-044072

Insider Transaction Report

Form 3
Period: 2024-04-16
Soffer Rochel
10% Owner
Holdings
  • Common Stock

    3,178,137
  • Common Stock

    (indirect: See Footnote)
    2,750,000
Holdings
  • Common Stock

    3,178,137
  • Common Stock

    (indirect: See Footnote)
    2,750,000
Footnotes (2)
  • [F1]Of the 5,928,137 Shares reported, 3,178,137 shares of common stock are held by Rochel Soffer individually and 2,750,000 shares of common stock are held by Alpha Pharma Investments LLC (collectively, the "Reporting Persons"). Rochel Soffer, as the sole member and beneficiary of Alpha Pharma Investments LLC has voting and dispositive power of Alpha Pharma Investments LLC.
  • [F2]The Reporting Persons disclaims beneficial ownership of all securities owned by Yair Schneid, the spouse of Rochel Soffer, except to the extent of their pecuniary interest therein, if any.

Documents

1 file

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0002018003

Filing Metadata

Form type
3
Filed
May 15, 8:00 PM ET
Accepted
May 16, 10:26 AM ET
Size
6.8 KB